Lesson plan
Clorgiline
Clorgiline ( ), or clorgyline ( ), is a monoamine oxidase inhibitor (MAOI) and investigational antidepressant related to pargyline. Specifically, it is an irreversible and selective inhibitor of monoamine oxidase A (MAO-A). Clorgiline was never marketed, but it has found use in scientific research. In addition to its MAOI activity, it has been found to bind with high affinity to the σ 1 receptor (K i = 3.2–510 nM) and with very high affinity to the imidazoline I 2 receptor (K i = 40 pM). Unlike selegiline, clorgiline does not appear to be a monoaminergic activity enhancer (MAE). Clorgiline is also a multidrug efflux pump inhibitor. Holmes et al., 2012 reverse azole fungicide resistance using clorgiline, showing promise for its use in multiple fungicide resistance.
Article summary
Clorgiline ( ), or clorgyline ( ), is a monoamine oxidase inhibitor (MAOI) and investigational antidepressant related to pargyline. Specifically, it is an irreversible and selective inhibitor of monoamine oxidase A (MAO-A). Clorgiline was never marketed, but it has found use in scientific research. In addition to its MAOI activity, it has been found to bind with high affinity to the σ 1 receptor (K i = 3.2–510 nM) and with very high affinity to the imidazoline I 2 receptor (K i = 40 pM). Unlike selegiline, clorgiline does not appear to be a monoaminergic activity enhancer (MAE). Clorgiline is also a multidrug efflux pump inhibitor. Holmes et al., 2012 reverse azole fungicide resistance using clorgiline, showing promise for its use in multiple fungicide resistance.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.